Is obesity a prognostic factor for acute myeloid leukemia outcome?

Annals of Hematology

Volumn 91, Issue 3, 2012, Pages 359-365

  Lee, Hun Ju ^a   Licht, Andrea S ^a   Hyland, Andrew J ^a   Ford, Laurie A ^a   Sait, Sheila N J ^a   Block, Annemarie W ^a   Barcos, Maurice ^a   Baer, Maria R ^a,b   Wang, Eunice S ^a   Wetzler, Meir ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

^b UNIVERSITY OF MARYLAND   (United States)

Author keywords

Acute myeloid leukemia; Body mass index; Obesity; Outcome

Indexed keywords

ARSENIC TRIOXIDE; CYTARABINE; IDARUBICIN;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; BODY MASS; CARDIOTOXICITY; CONTROLLED STUDY; DRUG MEGADOSE; FEMALE; HUMAN; INFECTIOUS COMPLICATION; KARYOTYPE; LUNG DISEASE; MAJOR CLINICAL STUDY; MALE; OBESITY; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; SMOKING; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIBIOTICS, ANTINEOPLASTIC; ANTIMETABOLITES, ANTINEOPLASTIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BODY MASS INDEX; CLINICAL TRIALS, PHASE I AS TOPIC; CYTARABINE; DATABASES, FACTUAL; FEMALE; HUMANS; IDARUBICIN; KAPLAN-MEIER ESTIMATE; LEUKEMIA, MYELOID, ACUTE; MALE; MIDDLE AGED; OBESITY; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84857365045     PISSN: 09395555     EISSN: 14320584     Source Type: Journal    
DOI: 10.1007/s00277-011-1319-8     Document Type: Article

References (28)

1. EE Calle, et al. 2003 Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults N Engl J Med 348 17 1625 1638 12711737 10.1056/NEJMoa021423 (Pubitemid 36459468)
2. MA Lichtman 2010 Obesity and the risk for a hematological malignancy: leukemia, lymphoma, or myeloma Oncologist 15 10 1083 1101 20930095 10.1634/theoncologist.2010-0206
3. RJ Hunter, et al. 2009 Dosing chemotherapy in obese patients: actual versus assigned body surface area (BSA) Cancer Treat Rev 35 1 69 78 18922643 10.1016/j.ctrv.2008.07.005 1:CAS:528:DC%2BD1MXhtlSmuro%3D
4. A Sparreboom, et al. 2007 Evaluation of alternate size descriptors for dose calculation of anticancer drugs in the obese J Clin Oncol 25 30 4707 4713 17947717 10.1200/JCO.2007.11.2938 1:CAS:528:DC%2BD2sXhtlCgsLjJ (Pubitemid 350086471)
5. BJ Lange, et al. 2005 Mortality in overweight and underweight children with acute myeloid leukemia JAMA 293 2 203 211 15644547 10.1001/jama.293.2.203 1:CAS:528:DC%2BD2MXktVyqsA%3D%3D (Pubitemid 40095871)
6. BJ Lange, et al. 2008 Outcomes in CCG-2961, a children's oncology group phase 3 trial for untreated pediatric acute myeloid leukemia: a report from the children's oncology group Blood 111 3 1044 1053 18000167 10.1182/blood-2007-04- 084293 1:CAS:528:DC%2BD1cXhvFejsb4%3D (Pubitemid 351213382)
7. (2004) Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 363(9403): p. 157-63
8. BD Cheson, et al. 2003 Revised recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia J Clin Oncol 21 24 4642 4649 14673054 10.1200/JCO.2003.04.036 (Pubitemid 46594039)
9. JC Byrd, et al. 2002 Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461) Blood 100 13 4325 4336 12393746 10.1182/blood-2002-03-0772 1:CAS:528:DC%2BD38XpsFCqs7o%3D (Pubitemid 35429670)
10. SC Larsson A Wolk 2008 Overweight and obesity and incidence of leukemia: a meta-analysis of cohort studies Int J Cancer 122 6 1418 1421 18027857 10.1002/ijc.23176 1:CAS:528:DC%2BD1cXit1yht7k%3D (Pubitemid 351287244)
11. JA Ross, et al. 2004 Body mass index and risk of leukemia in older women Cancer Epidemiol Biomarkers Prev 13 11 Pt 1 1810 1813 15533912 (Pubitemid 39482961)
12. J Tedesco, et al. 2011 High prevalence of obesity in acute promyelocytic leukemia (APL): implications for differentiating agents in APL and metabolic syndrome Ther Adv Hematol 2 3 141 145 10.1177/2040620711408490 1:CAS:528:DC%2BC3MXhsV2kurjM
13. A Wang, et al. 2005 Obesity and weight control practices in 2000 among veterans using VA facilities Obes Res 13 8 1405 1411 16129723
14. (2009) Obesity trends among U.S. adults. CDC
15. A Must GE Dallal WH Dietz 1991 Reference data for obesity: 85th and 95th percentiles of body mass index (wt/ht2) and triceps skinfold thickness Am J Clin Nutr 53 4 839 846 2008861 1:STN:280:DyaK3M7otFGksQ%3D%3D (Pubitemid 21898844)
16. SJ Appel JS Harrell ML Davenport 2005 Central obesity, the metabolic syndrome, and plasminogen activator inhibitor-1 in young adults J Am Acad Nurse Pract 17 12 535 541 16293162 10.1111/j.1745-7599.2005.00083.x
17. EE Frezza MS Wachtel M Chiriva-Internati 2006 Influence of obesity on the risk of developing colon cancer Gut 55 2 285 291 16239255 10.1136/gut.2005. 073163 1:STN:280:DC%2BD28%2FitVSkuw%3D%3D (Pubitemid 43117290)
18. AM Haydon, et al. 2006 Effect of physical activity and body size on survival after diagnosis with colorectal cancer Gut 55 1 62 67 15972299 10.1136/gut.2005.068189 1:STN:280:DC%2BD2Mnmt1Srug%3D%3D (Pubitemid 41820637)
19. L Busetto, et al. 2005 Obstructive sleep apnea syndrome in morbid obesity: effects of intragastric balloon Chest 128 2 618 623 16100146 10.1378/chest.128.2.618 (Pubitemid 41140488)
20. N Hatipoglu, et al. 2010 Neck circumference: an additional tool of screening overweight and obesity in childhood Eur J Pediatr 169 6 733 739 19936785 10.1007/s00431-009-1104-z
21. M Ashwell SD Hsieh 2005 Six reasons why the waist-to-height ratio is a rapid and effective global indicator for health risks of obesity and how its use could simplify the international public health message on obesity Int J Food Sci Nutr 56 5 303 307 16236591 10.1080/09637480500195066 (Pubitemid 41631661)
22. E Estey, et al. 1997 Association between increased body mass index and a diagnosis of acute promyelocytic leukemia in patients with acute myeloid leukemia Leukemia 11 10 1661 1664 9324286 10.1038/sj.leu.2400783 1:STN:280:DyaK2svmsVCltw%3D%3D (Pubitemid 27458604)
23. R Jeddi, et al. 2010 High body mass index is an independent predictor of differentiation syndrome in patients with acute promyelocytic leukemia Leuk Res 34 4 545 547 19800119 10.1016/j.leukres.2009.09.017
24. R Jeddi, et al. 2008 Predictive factors of all-trans-retinoic acid related complications during induction therapy for acute promyelocytic leukemia Hematology 13 3 142 146 18702871 10.1179/102453308X316112 1:CAS:528: DC%2BD1cXhtFOjtb7O
25. WH Navarro, et al. 2010 Obesity does not preclude safe and effective myeloablative hematopoietic cell transplantation (HCT) for acute myelogenous leukemia (AML) in adults Biol Blood Marrow Transpl 16 10 1442 1450 10.1016/j.bbmt.2010.04.009
26. AK Haque, et al. 2008 Pulmonary and cardiovascular complications of obesity: an autopsy study of 76 obese subjects Arch Pathol Lab Med 132 9 1397 1404 18788850
27. P Mathieu I Lemieux JP Despres 2010 Obesity, inflammation, and cardiovascular risk Clin Pharmacol Ther 87 4 407 416 20200516 10.1038/clpt.2009.311 1:STN:280:DC%2BC3c7pvVSgtg%3D%3D
28. AR Derolf, et al. 2009 Improved patient survival for acute myeloid leukemia: a population-based study of 9729 patients diagnosed in Sweden between 1973 and 2005 Blood 113 16 3666 3672 19020306 10.1182/blood-2008-09-179341 1:CAS:528:DC%2BD1MXlt1yjs7g%3D